CD33 is highly expressed in acute promyelocytic leukemia (APL), NPM1-mutated AML, and FLT3/ITD mutated AML, whereas expression is usually low in leukemias with core-binding factor translocations (45). Here, CD33 is linked to acute promyelocytic leukemia.